EWTX
Edgewise Therapeutics, Inc.
+1.58 (+3.48%)47.02USD748K成交股數5.1B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 47.5M | 42.7M | 37.5M | 33.6M | 36.8M | 36.4M | 32.2M | 30.7M | 27.7M | 23.8M | 19.6M | 19.9M |
| 銷售管理費用 | 14.4M | 11.5M | 9.4M | 9.1M | 9.2M | 9.2M | 8.2M | 7.4M | 7.1M | 5.7M | 5.8M | 5.8M |
| 營業利益 | −61.9M+35% | −54.1M+19% | −46.9M+16% | −42.6M+12% | −46.0M+32% | −45.5M+55% | −40.4M+60% | −38.1M+48% | −34.8M | −29.5M | −25.3M | −25.7M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −57.3M+41% | −49.0M-152% | −40.7M+19% | −36.1M+15% | −40.8M+43% | 94.0M-466% | −34.1M+59% | −31.5M+38% | −28.5M | −25.7M | −21.5M | −22.8M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.53+23% | -0.46+10% | -0.39+8% | -0.340% | -0.43+30% | -0.42+2% | -0.36+6% | -0.34-6% | -0.33 | -0.41 | -0.34 | -0.36 |
| 稀釋股數 | 108M | 107M | 105M | 105M | 95.1M | 92.4M | 93.8M | 93.5M | 87.6M | 63.5M | 63.4M | 63.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 72.3M | 33.2M | 46.0M | 43.4M | 49.9M | 41.7M | 44.8M | 43.5M | 30.3M | 33.0M | 31.8M | 48.2M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 480M | 519M | 583M | 613M | 454M | 487M | 511M | 532M | 554M | 311M | 331M | 346M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 31.6M | 25.3M | 24.8M | 24.3M | 24.7M | 27.6M | 22.4M | 21.2M | 18.9M | 20.9M | 19.2M | 17.6M |
| 股東權益 | 448M | 493M | 559M | 589M | 430M | 459M | 489M | 510M | 535M | 290M | 311M | 329M |
| 負債比 | 6.6% | 4.9% | 4.3% | 4.0% | 5.4% | 5.7% | 4.4% | 4.0% | 3.4% | 6.7% | 5.8% | 5.1% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −42.5M | – | – | −37.9M+32% | – | – | – | −28.6M | – | – | −22.8M |
| 資本支出 | – | 260K | – | – | 44K | – | – | – | 297K | – | – | 4.4M |
| 自由現金流 | – | −42.8M | – | – | −37.9M+31% | – | – | – | −28.9M | – | – | −27.2M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −168K | –% | -1.63 | −144M |
| FY2024 | – | – | −134K | –% | -1.45 | −110M |
| FY2023 | – | – | −100K | –% | -1.57 | −97.7M |
| FY2022 | – | – | −67.6M | –% | -1.26 | −58.2M |
| FY2021 | – | – | −42.8M | –% | -1.14 | −34.2M |
| FY2020 | – | – | −17.1M | –% | -23.17 | −14.8M |